Financial Statements — IFRX
Balance Sheet
(in millions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Cash & Equivalents | 13.00 | 19.15 | 19.52 | 15.42 |
| Inventory | 5.04 | 9.64 | 0.58 | -- |
| Total Current Assets | 66.17 | 91.30 | 112.22 | 112.13 |
| Total Non-current Assets | 7.27 | 1.74 | 20.74 | 2.50 |
| Total Assets | 73.44 | 93.04 | 132.96 | 114.63 |
| Total Current Liabilities | 16.16 | 10.24 | 7.47 | 11.29 |
| Total Non-current Liabilities | 0.24 | 0.64 | 0.85 | 1.21 |
| Total Liabilities | 16.40 | 10.88 | 8.32 | 12.50 |
| Retained Earnings | (354.92) | (309.63) | (262.75) | (227.51) |
| Total Stockholder Equity | 57.04 | 82.16 | 124.65 | 102.13 |
Income Statement
(in millions EUR) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Total Revenue | 0.04 | 0.01 | -- | -- |
| Cost of Revenue* | 2.40 | 0.35 | -- | -- |
| Gross Profit | (2.36) | (0.34) | -- | -- |
| Research & Development | 7.20 | 10.02 | 10.92 | 11.18 |
| Selling, General & Admin | 3.28 | 3.23 | 3.54 | 4.35 |
| Total Operating Expenses | -- | -- | -- | (15.53) |
| Interest Expense | -- | -- | 0.00 | 0.00 |
| Pretax Income | -- | -- | (19.29) | (13.54) |
| Tax Provision | -- | -- | -- | 0.00 |
| Net Income | (14.42) | (13.85) | (8.20) | 0.47 |
| Basic EPS | (0.21) | (0.24) | (0.14) | -- |
| Diluted EPS | (0.21) | (0.24) | (0.14) | 0.01 |
* Derived from reported values
Cash Flow Statement
(in millions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Operating Cash Flow | (21.57) | (27.00) | (21.69) | (25.36) |
| Investing Cash Flow | (7.25) | 32.94 | (27.89) | 12.55 |
| Financing Cash Flow | 26.91 | (0.19) | 53.18 | (0.18) |
